Ocugen Inc

Company Profile

Ocugen Inc had its IPO on 2014-12-03 under the ticker symbol OCGN.

The company operates in the Healthcare sector and Biotechnology industry. Ocugen Inc has a staff strength of 84 employees.

Stock update

Shares of Ocugen Inc opened at $0.42 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.42 - $0.44, and closed at $0.42.

This is a 0% increase from the previous day's closing price.

A total volume of 989,958 shares were traded at the close of the day’s session.

In the last one week, shares of Ocugen Inc have slipped by -2.33%.

Ocugen Inc's Key Ratios

Ocugen Inc has a market cap of $110.29 million, indicating a price to book ratio of 3.6519 and a price to sales ratio of 25069.316.

In the last 12-months Ocugen Inc’s revenue was $-380 with a gross profit of $-49757000 and an EBITDA of $-89191000. The EBITDA ratio measures Ocugen Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Ocugen Inc’s operating margin was 0% while its return on assets stood at -51.27% with a return of equity of -90.34%.

In Q2, Ocugen Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Ocugen Inc’s PE and PEG Ratio

Forward PE

15.2207

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.35 per share while it has a forward price to earnings multiple of 15.2207 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Ocugen Inc’s profitability.

Ocugen Inc stock is trading at a EV to sales ratio of 35591.278 and a EV to EBITDA ratio of -3.3624. Its price to sales ratio in the trailing 12-months stood at 25069.316.

Ocugen Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$88.98 million

Total Liabilities

$13.46 million

Operating Cash Flow

$5.72 million

Capital Expenditure

$2.78 million

Dividend Payout Ratio

0%

Ocugen Inc ended 2024 with $88.98 million in total assets and $0 in total liabilities. Its intangible assets were valued at $88.98 million while shareholder equity stood at $70.28 million.

Ocugen Inc ended 2024 with $0 in deferred long-term liabilities, $13.46 million in other current liabilities, 2566000.00 in common stock, $-252441000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $70.58 million and cash and short-term investments were $70.58 million. The company’s total short-term debt was $1,792,000 while long-term debt stood at $1.47 million.

Ocugen Inc’s total current assets stands at $73.45 million while long-term investments were $0 and short-term investments were $0.00. Its net receivables were $0 compared to accounts payable of $3.88 million and inventory worth $0.

In 2024, Ocugen Inc's operating cash flow was $5.72 million while its capital expenditure stood at $2.78 million.

Comparatively, Ocugen Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.42

52-Week High

$2.36

52-Week Low

$0.397

Analyst Target Price

$4.58

Ocugen Inc stock is currently trading at $0.42 per share. It touched a 52-week high of $2.36 and a 52-week low of $2.36. Analysts tracking the stock have a 12-month average target price of $4.58.

Its 50-day moving average was $0.52 and 200-day moving average was $0.85 The short ratio stood at 5.78 indicating a short percent outstanding of 0%.

Around 151.3% of the company’s stock are held by insiders while 2420.8% are held by institutions.